Perrigo Reports First Quarter 2026 Financial Results From Continuing Operations
Perrigo reported Q1 Core adjusted EPS of $0.40, topping expectations, while total revenue declined 7.2% year-over-year to $969 million. Results were weighed down by a non-cash goodwill impairment charge of $330.8 million and lower consumption across U.S. and European markets, though Specialty Care segment sales grew.
Key figures
- Eps
- 0.43
- Eps Beat
- 0.05
- Revenue
- $969 million
- Guidance
- FY26 Core Adj. EPS $2.25-$2.55; reaffirmed
- Revenue Yoy
- -7.2%
- Core adj eps
- 0.4
- Core revenue
- $842 million
- Impairment charge
- $330.8 million
- Divestiture proceeds
- €306 million
- Core adj operating margin
- 12.8%
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.